CUSIP 91307C102 · who reports it, how much, and how much it matters to them
57 of the 720 hedge fund managers we track reported shares of UNITED THERAPEUTICS Corp (Nasdaq: UTHR) on Form 13F for 30 June 2026. Between them they reported USD 3.5bn. The largest position belongs to Avoro Capital Advisors, at USD 1.5bn.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Avoro Capital Advisors1 fund on PPLI.com | USD 1.5bn | 13.5% |
| 2 | Renaissance Technologies13 funds on PPLI.com | USD 926m | 1.3% |
| 3 | Millennium Management6 funds on PPLI.com | USD 222m | 0.1% |
| 4 | Citadel Advisors32 funds on PPLI.com | USD 165m | 0.0% |
| 5 | Eversept Partners3 funds on PPLI.com | USD 156m | 8.1% |
| 6 | POINT72 Asset Management17 funds on PPLI.com | USD 109m | 0.1% |
| 7 | Deep Track Capital1 fund on PPLI.com | USD 67m | 1.0% |
| 8 | Bridgewater Associates45 funds on PPLI.com | USD 60m | 0.2% |
| 9 | Sofinnova Investments1 fund on PPLI.com | USD 41m | 2.1% |
| 10 | Palo Alto Investors6 funds on PPLI.com | USD 34m | 4.7% |
| 11 | Capital Fund Management S.A.12 funds on PPLI.com | USD 29m | 0.1% |
| 12 | PFM Health Sciences3 funds on PPLI.com | USD 27m | 2.3% |
| 13 | Squarepoint Ops7 funds on PPLI.com | USD 26m | 0.0% |
| 14 | Marshall Wace LLP84 funds on PPLI.com | USD 16m | 0.0% |
| 15 | Ardsley Advisory Partners6 funds on PPLI.com | USD 16m | 1.7% |
| 16 | Persistent Asset Partners10 funds on PPLI.com | USD 7.6m | 2.3% |
| 17 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 7.2m | 0.4% |
| 18 | Tudor Investment Corporation10 funds on PPLI.com | USD 6.9m | 0.0% |
| 19 | Two Sigma Investments35 funds on PPLI.com | USD 6.8m | 0.0% |
| 20 | Rokos Capital Management LLP1 fund on PPLI.com | USD 5.8m | 0.0% |
| 21 | Aquatic Capital Management3 funds on PPLI.com | USD 5.5m | 0.2% |
| 22 | IFM Investors Pty7 funds on PPLI.com | USD 5.2m | 0.0% |
| 23 | Edgestream Partners5 funds on PPLI.com | USD 5m | 0.1% |
| 24 | Voleon Capital Management13 funds on PPLI.com | USD 4.1m | 0.1% |
| 25 | Superstring Capital Management1 fund on PPLI.com | USD 3.9m | 2.5% |
| 26 | CIBC Asset Management69 funds on PPLI.com | USD 3.4m | 0.0% |
| 27 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 3.4m | 0.0% |
| 28 | Atom Investors1 fund on PPLI.com | USD 3.3m | 0.3% |
| 29 | Exome Asset Management2 funds on PPLI.com | USD 2.9m | 1.8% |
| 30 | Formula Growth6 funds on PPLI.com | USD 2.9m | 1.0% |
| 31 | Hudson Bay Capital Management8 funds on PPLI.com | USD 2.7m | 0.0% |
| 32 | Artia Global Partners1 fund on PPLI.com | USD 2.7m | 0.5% |
| 33 | Engineers Gate Manager1 fund on PPLI.com | USD 2.5m | 0.0% |
| 34 | Brevan Howard Capital Management39 funds on PPLI.com | USD 2.3m | 0.0% |
| 35 | LMR Partners2 funds on PPLI.com | USD 2.1m | 0.0% |
| 36 | Verition Fund Management3 funds on PPLI.com | USD 2m | 0.0% |
| 37 | Lighthouse Investment Partners190 funds on PPLI.com | USD 1.9m | 0.1% |
| 38 | Grantham Mayo Van Otterloo & Co1 fund on PPLI.com | USD 1.8m | 0.0% |
| 39 | Partners Capital Investment Group, LLP26 funds on PPLI.com | USD 1.7m | 0.1% |
| 40 | Balyasny Asset Management25 funds on PPLI.com | USD 1.3m | 0.0% |
| 41 | Weiss Asset Management5 funds on PPLI.com | USD 1.2m | 0.0% |
| 42 | Acuta Capital Partners2 funds on PPLI.com | USD 1.2m | 0.8% |
| 43 | HighVista Strategies27 funds on PPLI.com | USD 1.1m | 0.3% |
| 44 | Holocene Advisors2 funds on PPLI.com | USD 845,000 | 0.0% |
| 45 | Exoduspoint Capital Management7 funds on PPLI.com | USD 745,000 | 0.0% |
| 46 | Jain Global1 fund on PPLI.com | USD 703,000 | 0.0% |
| 47 | Freestone Grove Partners1 fund on PPLI.com | USD 654,000 | 0.0% |
| 48 | Capstone Investment Advisors25 funds on PPLI.com | USD 608,000 | 0.0% |
| 49 | Lecap Asset Management1 fund on PPLI.com | USD 595,000 | 0.3% |
| 50 | Boothbay Fund Management2 funds on PPLI.com | USD 424,000 | 0.0% |
| 51 | BTG Pactual Asset Management US11 funds on PPLI.com | USD 366,000 | 0.0% |
| 52 | DG Capital Management3 funds on PPLI.com | USD 302,000 | 0.1% |
| 53 | Prelude Capital Management9 funds on PPLI.com | USD 299,000 | 0.0% |
| 54 | Oxford Asset Management LLP2 funds on PPLI.com | USD 234,000 | 0.1% |
| 55 | Graticule Asia Macro Advisors8 funds on PPLI.com | USD 34,135 | 0.0% |
| 56 | The Quarry1 fund on PPLI.com | USD 1,625 | 0.0% |
| 57 | Summit Global Investments1 fund on PPLI.com | USD 1,009 | 0.1% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Avoro Capital Advisors | USD 1.5bn | 13.5% |
| 2 | Eversept Partners | USD 156m | 8.1% |
| 3 | Palo Alto Investors | USD 34m | 4.7% |
| 4 | Superstring Capital Management | USD 3.9m | 2.5% |
| 5 | PFM Health Sciences | USD 27m | 2.3% |
| 6 | Persistent Asset Partners | USD 7.6m | 2.3% |
| 7 | Sofinnova Investments | USD 41m | 2.1% |
| 8 | Exome Asset Management | USD 2.9m | 1.8% |
| 9 | Ardsley Advisory Partners | USD 16m | 1.7% |
| 10 | Renaissance Technologies | USD 926m | 1.3% |
UNITED THERAPEUTICS Corp trades under the symbol UTHR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 91307C102.
57 of the 720 hedge fund managers PPLI.com tracks reported UNITED THERAPEUTICS Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Avoro Capital Advisors (USD 1.5bn), Renaissance Technologies (USD 926m), Millennium Management (USD 222m), Citadel Advisors (USD 165m) and Eversept Partners (USD 156m).
57 managers in our coverage reported it, and between them they run 842 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Avoro Capital Advisors, where the position was 13.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with UNITED THERAPEUTICS Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.